A significant link has been found between allelic variation of the promotor (21260) C/apolimorphism and AD, concluding therefore that the polymorphism C/A of the promotor CYP27B1 (21260) seems to be linked to endocrinal autoimmune diseases. Here, CYP27B1 is linked to Alzheimer disease.